CryoPort Announces Full Integration with DHL Ordering Systems for Frozen Shipping Service

DHL Customers Now Have a Seamless Process for Shipping Critical Biological Material Worldwide

SAN DIEGO--(BUSINESS WIRE)-- CryoPort, Inc. (OTCBB: CYRX) today announced that it has completed the integration of its sophisticated order entry and tracking web portal with DHL's ordering and billing systems. DHL's life science customers around the world can now order directly from CryoPort and receive preferred DHL shipping rates.

"We are very pleased that DHL is offering its customers direct access to the CryoPort Express(R) Dry Shipper through our fully integrated, easy-to-use ordering system," said Larry Stambaugh, CryoPort's Chairman and Chief Executive Officer. "Because the CryoPort Express system is an end-to-end solution, DHL customers can prepare a complete shipment order in six simple steps on our portal. Our current customers tell us that the speed and convenience of our service allows them to spend more time on their business and less on paperwork and packaging."

The reusable CryoPort Express Dry Shipper is designed to meet the needs of clinical labs, diagnostic companies, research organizations, and the biotech and pharmaceutical industries by allowing tissue samples, blood and other biological material to remain frozen at or below -150C for 10+ days, in contrast to the current industry practice of dry-ice packaging, which often requires re-icing during transit.

About CryoPort, Inc.

CryoPort ( has developed a leading edge, proprietary, technology-driven transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. The products developed by CryoPort have a 10+ day holding time, are using "green" materials and are essential components of the infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex global logistical environment.

Forward Looking Statements

Statements in this press release which are not purely historical, including statements regarding CryoPort, Inc.'s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company's business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2010. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. CryoPort, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

    Source: CryoPort, Inc.